Cross-sectional burden-of-illness study in atopic dermatitis (MEASURE-AD) in Australia and New Zealand reveals impacts on well-being.

Marius Rademaker Paul Jarrett Dedee Frances Murrell Rodney Daniel SinclairLauren PasfieldDavid PoppelwellStephen Shumack

Published in: The Australasian journal of dermatology (2024)

ANZ patients with AD have a high disease burden, which extends across multiple facets of daily life. Many are inadequately controlled with existing therapies.

Keyphrases

atopic dermatitis
cross sectional
physical activity
risk factors